Display options
Cite
Pyclik M, Górska S, Brzozowska E, et al. Epitope Mapping of . Front Microbiol. 2018;9:125doi: 10.3389/fmicb.2018.00125.
Pyclik, M., Górska, S., Brzozowska, E., Dobrut, A., Ciekot, J., Gamian, A., & Brzychczy-Włoch, M. (2018). Epitope Mapping of . Frontiers in microbiology, 9125. https://doi.org/10.3389/fmicb.2018.00125
Pyclik, Marcelina, et al. "Epitope Mapping of ." Frontiers in microbiology vol. 9 (2018): 125. doi: https://doi.org/10.3389/fmicb.2018.00125
Pyclik M, Górska S, Brzozowska E, Dobrut A, Ciekot J, Gamian A, Brzychczy-Włoch M. Epitope Mapping of . Front Microbiol. 2018 Feb 06;9:125. doi: 10.3389/fmicb.2018.00125. eCollection 2018. PMID: 29467739; PMCID: PMC5808131.
Copy Download .nbib Format: NLM
Share it on

Front Microbiol. 2018 Feb 06;9:125. doi: 10.3389/fmicb.2018.00125. eCollection 2018.

Epitope Mapping of .

Frontiers in microbiology

Marcelina Pyclik, Sabina Górska, Ewa Brzozowska, Anna Dobrut, Jarosław Ciekot, Andrzej Gamian, Monika Brzychczy-Włoch

Affiliations

  1. Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland.
  2. Chair of Microbiology, Department of Molecular Medical Microbiology, Jagiellonian University Medical College, Krakow, Poland.

PMID: 29467739 PMCID: PMC5808131 DOI: 10.3389/fmicb.2018.00125

Abstract

The elongation factor Tu has been identified as one of the most immunoreactive proteins that was recognized by human sera of GBS (group B streptococcus) positive patients. In this paper, we present the polypeptide-specific epitopes of the bacterial protein that are recognized by human antibodies:

Keywords: ELISA; PEPSCAN; Streptococcus agalactiae; elongation factor Tu; epitope mapping; group B streptococcus; synthetic peptide; vaccination

References

  1. J Reprod Med. 1999 Jul;44(7):587-91 - PubMed
  2. Clin Chem. 2000 Mar;46(3):324-31 - PubMed
  3. Eur J Clin Microbiol Infect Dis. 2001 Feb;20(2):120-2 - PubMed
  4. MMWR Recomm Rep. 2002 Aug 16;51(RR-11):1-22 - PubMed
  5. Eur J Clin Microbiol Infect Dis. 2004 Jan;23(1):61-2 - PubMed
  6. J Biol Chem. 1951 Nov;193(1):265-75 - PubMed
  7. Infect Immun. 2004 Apr;72(4):2160-9 - PubMed
  8. Immunome Res. 2006 Apr 24;2:2 - PubMed
  9. J Mol Microbiol Biotechnol. 2006;11(3-5):228-43 - PubMed
  10. Protein Sci. 2006 Nov;15(11):2558-67 - PubMed
  11. FEBS Lett. 1990 Dec 10;276(1-2):172-4 - PubMed
  12. Diagn Microbiol Infect Dis. 2007 Sep;59(1):17-22 - PubMed
  13. J Immunol. 2007 Sep 1;179(5):2979-88 - PubMed
  14. Mem Inst Oswaldo Cruz. 2008 Mar;103(2):186-90 - PubMed
  15. MMWR Recomm Rep. 2010 Nov 19;59(RR-10):1-36 - PubMed
  16. Vaccine. 2013 Aug 28;31 Suppl 4:D20-6 - PubMed
  17. Med Sci Monit. 2013 Jan 11;19:34-9 - PubMed
  18. Pediatr Infect Dis J. 2013 Jul;32(7):e265-71 - PubMed
  19. MBio. 2013 May 07;4(3):e00207-13 - PubMed
  20. Vaccine. 2013 Aug 28;31 Suppl 4:D43-5 - PubMed
  21. FEMS Microbiol Lett. 2013 Dec;349(1):61-70 - PubMed
  22. J Immunol Methods. 1987 Sep 24;102(2):259-74 - PubMed
  23. Pol J Microbiol. 2013;62(4):427-33 - PubMed
  24. Mol Immunol. 2014 Nov;62(1):249-64 - PubMed
  25. Front Genet. 2015 Jun 19;6:211 - PubMed
  26. Emerg Microbes Infect. 2015 Sep 02;4:e54 - PubMed
  27. PLoS One. 2016 Aug 18;11(8):e0161170 - PubMed
  28. Sci Rep. 2017 Sep 11;7(1):11227 - PubMed
  29. J Virol. 1985 Sep;55(3):836-9 - PubMed
  30. J Clin Microbiol. 1986 Aug;24(2):296-7 - PubMed
  31. Immunochemistry. 1975 May;12(5):423-38 - PubMed
  32. Infect Immun. 1996 Jan;64(1):277-82 - PubMed

Publication Types